Sign in
WithdrawnNo phase

Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
30 Oct 2026
Ended
30 Oct 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • H.A.L.T. MAX spectacles
Record updated
2 November 2026
Why it stopped
Major amendment for protocol

Who can take part

Age
7 years to 14 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Voluntary, willing to follow the protocol, able to read and understand the information form and give free and informed consent (for parents/guardian of children subjects) and assent (for subjects aged 7-14 years old)
  • 7-14 years old,regardless of sex
  • Spherical equivalent refraction (SE) after cyclopegia ≤ -5.00 D and ≥ -9.00D
  • Anisometropia and Astigmatism ≤2.50D
  • Best corrected distance visual acuity of at least 0.8 in both eyes
  • Willing to wear only the spectacles provided by the investigator for all days (>10 hours) during the study without additional interventions
  • Accept randomization
  • Able to sign the informed consent form with the accompaniment and understanding of parents or guardians

Who cannot take part

  • Exclude children on high dose atropine (1%) or red light therapy;
  • Any previous history of myopia control treatment in the previous 30 days, like low dose atropine, defocus spectacles, or thokeratology and acupuncture;
  • Allergic or intolerant to cycloplegic drugs;
  • History or presence of an ocular disease, strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, and cataract.;
  • History of eye surgery;
  • Ocular or systemic diseases that may be associated with myopia, such as Marfan syndrome, retinopathy of newborns, diabetes, etc;
  • Other conditions unsuitable for inclusion (patients with excessive expectations for the effect of the defocus spectacle lenses or desires to try other myopia interventions)
  • Anatomic or skin factors affecting the wearing of spectacles;

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Children aged 7-14 years with high myopia were randomly assigned to a control group or an intervention group at a 1:1 ratio. The intervention group wore H.A.L.T. MAX lenses for at least 10 hours per day for 2 years, and the control group wore ordinary single-vision (SV) spectacles for at least 10 hours per day. At the 1-year follow-up examination (6-month visit), control subjects whose equivalent spherical diopter change (SER) was ≥0.75 D were switched to H.A.L.T. MAX lenses until the end of year 2. After entering year 2, all remaining control (SV) subjects will be replaced with H.A.L.T. MAX defofocus frames for at least 10 hours per day until the end of year 2. And continue to wear it for at least 10 hours per day. To evaluate the efficacy, safety and compliance of H.A.L.T. MAX lenses in delaying myopia progression in children with high myopia, and to provide a scientific basis for the formulation and practice of public health programs for delaying myopia progression and the risk of blindness and visual impairment caused by high myopia.

The 2 groups in the trial

  • the intervention groupTreatment being tested

    the intervention group wore H.A.L.T. MAX for at least 10 hours a day for 2 years.

    Treatment: H.A.L.T. MAX spectacles

  • The control groupNo study treatment, for comparison

    The control group will wear single vision lenses (SV) for at least 10 hours a day. In the first year (at 6-month follow-up), study participants in the control group with a spherical equivalent diopter change (SER) of ≥0.75 D will be switched to H.A.L.T. MAX lenses until the end of year 2. After entering year 2, all remaining control (SV) study participants will be replaced with H.A.L.T. MAX spectacles for at least 10 hours per day until the end of year 2.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of Spectacle Lenses With Maximized Highly Aspherical Lenslets Target Technology (H.A.L.T. MAX) on High Myopia Control in Children and Adolescents: a Randomized Controlled Research
Record updated
2 November 2026